Canada markets closed

Nuvo Pharmaceuticals Inc. (MRVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4770-0.1269 (-21.01%)
At close: 10:29AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.6039
Open0.4770
BidN/A x N/A
AskN/A x N/A
Day's Range0.4770 - 0.4770
52 Week Range0.4200 - 1.2500
Volume2,000
Avg. Volume2,082
Market Cap5.635M
Beta (5Y Monthly)1.40
PE Ratio (TTM)N/A
EPS (TTM)-0.9640
Earnings DateNov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Miravo Healthcare™ Announces Third Quarter 2022 Results

    MISSISSAUGA, Ontario, November 14, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three and nine months ended September 30, 2022. For further details on the results, please refer to Miravo’s Management, Discussion and Analysis (MD&A) and Condensed Consolidated Interim Fina

  • Business Wire

    Miravo Healthcare™ Announces Third Quarter 2022 Results Release Date and Conference Call Details

    MISSISSAUGA, Ontario,, October 31, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its third quarter 2022 financial results before markets open on Monday, November 14, 2022.

  • Business Wire

    Miravo Healthcare™ Announces Appointment of Anthony Snow to its Board of Directors

    MISSISSAUGA, Ontario, August 16, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced the appointment of Anthony Snow to its Board of Directors (Board) on August 12, 2022.